Literature DB >> 18071697

Chronic partial ureteral obstruction and the developing kidney.

Robert L Chevalier1.   

Abstract

Although congenital urinary tract obstruction is a common disorder, its pathophysiology remains poorly understood and clinical practice is controversial. Animal models have been used to elucidate the mechanisms responsible for obstructive nephropathy, and the models reveal that renal growth and function are impaired in proportion to the severity and duration of obstruction. Ureteral obstruction in the neonatal rat or mouse leads to activation of the renin-angiotensin system, renal infiltration by macrophages, and tubular apoptosis. Nephrons are lost by glomerular sclerosis and the formation of atubular glomeruli, and progressive injury leads to tubular atrophy and interstitial fibrosis. Recovery following release of obstruction depends on the timing, severity, and duration of obstruction. Growth factors and cytokines are produced by the hydronephrotic kidney, including MCP-1 and TGF-beta1, which are excreted in urine and can serve as biomarkers of renal injury. Because MRI can be used to monitor renal morphology, blood flow, and filtration rate, its use might supplant current imaging modalities (ultrasonography and diuretic renography), which have significant drawbacks. Combined use of MRI and new urinary biomarkers should improve our understanding of human congenital obstructive nephropathy and should lead to new approaches to evaluation and management of this challenging group of patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18071697     DOI: 10.1007/s00247-007-0585-z

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  64 in total

1.  Unilateral ureteral obstruction in neonatal rats leads to renal insufficiency in adulthood.

Authors:  R L Chevalier; B A Thornhill; A Y Chang
Journal:  Kidney Int       Date:  2000-11       Impact factor: 10.612

2.  Recovery following relief of unilateral ureteral obstruction in the neonatal rat.

Authors:  R L Chevalier; A Kim; B A Thornhill; J T Wolstenholme
Journal:  Kidney Int       Date:  1999-03       Impact factor: 10.612

3.  Does delayed operation for pediatric ureteropelvic junction obstruction cause histopathological changes?

Authors:  S W Han; S E Lee; J H Kim; H J Jeong; K H Rha; S K Choi
Journal:  J Urol       Date:  1998-09       Impact factor: 7.450

4.  Micro-MRI methods to detect renal cysts in mice.

Authors:  Hisataka Kobayashi; Satomi Kawamoto; Martin W Brechbiel; Sang-Kyung Jo; Xuzhen Hu; Tianxin Yang; Bhalchandra A Diwan; Thomas A Waldmann; Jurgen Schnermann; Peter L Choyke; Robert A Star
Journal:  Kidney Int       Date:  2004-04       Impact factor: 10.612

5.  Hydronephrosis due to pelviureteric junction obstruction in infancy.

Authors:  J Valayer; G Adda
Journal:  Br J Urol       Date:  1982-10

6.  MR imaging of kidneys: functional evaluation using F-15 perfusion imaging.

Authors:  J Damien Grattan-Smith; Marcos R Perez-Bayfield; Richard A Jones; Stephen Little; Bruce Broecker; Edwin A Smith; Hal C Scherz; Andrew J Kirsch
Journal:  Pediatr Radiol       Date:  2003-03-13

7.  Ultrafast contrast enhanced magnetic resonance imaging of congenital hydronephrosis in a rat model.

Authors:  J Fichtner; D Spielman; R Herfkens; F G Boineau; J E Lewy; L M Shortliffe
Journal:  J Urol       Date:  1994-08       Impact factor: 7.450

8.  Results of systematic screening for minor degrees of fetal renal pelvis dilatation in an unselected population.

Authors:  Khalid Ismaili; Michelle Hall; Catherine Donner; Dominique Thomas; Danièle Vermeylen; Fred E Avni
Journal:  Am J Obstet Gynecol       Date:  2003-01       Impact factor: 8.661

9.  Predicting the clinical outcome of congenital unilateral ureteropelvic junction obstruction in newborn by urinary proteome analysis.

Authors:  Stephane Decramer; Stefan Wittke; Harald Mischak; Petra Zürbig; Michael Walden; François Bouissou; Jean-Loup Bascands; Joost P Schanstra
Journal:  Nat Med       Date:  2006-03-19       Impact factor: 53.440

10.  Prognostic significance of captopril renography for managing congenital unilateral hydronephrosis.

Authors:  Minu Bajpai; A Puri; M Tripathi; A Maini
Journal:  J Urol       Date:  2002-11       Impact factor: 7.450

View more
  11 in total

1.  Four-dimensional MRI of renal function in the developing mouse.

Authors:  Luke Xie; Ergys Subashi; Yi Qi; Mark A Knepper; G Allan Johnson
Journal:  NMR Biomed       Date:  2014-07-26       Impact factor: 4.044

Review 2.  Rationale for early treatment of polycystic kidney disease.

Authors:  Jared J Grantham
Journal:  Pediatr Nephrol       Date:  2014-07-15       Impact factor: 3.714

Review 3.  Birth weight, malnutrition and kidney-associated outcomes--a global concern.

Authors:  Valerie A Luyckx; Barry M Brenner
Journal:  Nat Rev Nephrol       Date:  2015-01-20       Impact factor: 28.314

4.  Live nephron imaging by MRI.

Authors:  Chunqi Qian; Xin Yu; Nikorn Pothayee; Stephen Dodd; Nadia Bouraoud; Robert Star; Kevin Bennett; Alan Koretsky
Journal:  Am J Physiol Renal Physiol       Date:  2014-09-03

Review 5.  Congenital ureteropelvic junction obstruction: human disease and animal models.

Authors:  Julie Klein; Julien Gonzalez; Mathieu Miravete; Cécile Caubet; Rana Chaaya; Stéphane Decramer; Flavio Bandin; Jean-Loup Bascands; Bénédicte Buffin-Meyer; Joost P Schanstra
Journal:  Int J Exp Pathol       Date:  2010-07-30       Impact factor: 1.925

6.  Magnetic resonance histology of age-related nephropathy in the Sprague Dawley rat.

Authors:  Luke Xie; Rachel E Cianciolo; Brian Hulette; Ha Won Lee; Yi Qi; Gary Cofer; G Allan Johnson
Journal:  Toxicol Pathol       Date:  2012-04-13       Impact factor: 1.902

7.  First-year profile of biomarkers for early detection of renal injury in infants with congenital urinary tract obstruction.

Authors:  Dusan Kostic; Glenda Priscila Neves Dos Santos Beozzo; Saulo Brasil do Couto; André Henrique Teruaki Kato; Laila Lima; Patricia Palmeira; Vera Lúcia Jornada Krebs; Victor Bunduki; Rossana Pulcineli Vieira Francisco; Marcelo Zugaib; Werther Brunow de Carvalho; Vera Hermina Kalika Koch
Journal:  Pediatr Nephrol       Date:  2019-01-29       Impact factor: 3.714

8.  Changes in cell fate determine the regenerative and functional capacity of the developing kidney before and after release of obstruction.

Authors:  Vidya K Nagalakshmi; Minghong Li; Soham Shah; Joseph C Gigliotti; Alexander L Klibanov; Frederick H Epstein; Robert L Chevalier; R Ariel Gomez; Maria Luisa S Sequeira-Lopez
Journal:  Clin Sci (Lond)       Date:  2018-12-05       Impact factor: 6.124

9.  Mechanoprotection by polycystins against apoptosis is mediated through the opening of stretch-activated K(2P) channels.

Authors:  Rémi Peyronnet; Reza Sharif-Naeini; Joost H A Folgering; Malika Arhatte; Martine Jodar; Charbel El Boustany; Claire Gallian; Michel Tauc; Christophe Duranton; Isabelle Rubera; Florian Lesage; York Pei; Dorien J M Peters; Stefan Somlo; Frederick Sachs; Amanda Patel; Eric Honoré; Fabrice Duprat
Journal:  Cell Rep       Date:  2012-03-08       Impact factor: 9.423

10.  Tolvaptan suppresses monocyte chemotactic protein-1 excretion in autosomal-dominant polycystic kidney disease.

Authors:  Jared J Grantham; Arlene B Chapman; Jaime Blais; Frank S Czerwiec; Olivier Devuyst; Ron T Gansevoort; Eiji Higashihara; Holly Krasa; Wen Zhou; John Ouyang; Ronald D Perrone; Vicente E Torres
Journal:  Nephrol Dial Transplant       Date:  2017-06-01       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.